Citation Impact

Citing Papers

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC
2018
Hallmarks of Cancer: The Next Generation
2011 Standout
Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells
2006
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Differential recognition of heat‐shock protein dnaJ–derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis
2007
Fracture healing: mechanisms and interventions
2014 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors
2017 Nature
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
HLA class II antigen presentation by prostate cancer cells
2007
Juvenile idiopathic arthritis
2007 Standout
Mesenchymal stem cells in health and disease
2008 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
2021
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
2017 Nature
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape
2019 StandoutNobel
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cells
2015
Inflammation and Colon Cancer
2010 Standout
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
Targeting macrophages: therapeutic approaches in cancer
2018
Immunopathology of multiple sclerosis
2015 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Microenvironmental regulation of metastasis
2008 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging
2011
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Pattern recognition receptors: immune targets to enhance cancer immunotherapy
2017
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
2018
Neutrophils in cancer: neutral no more
2016 Standout
Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration
2006
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Immunomodulatory Properties of Mesenchymal Stem Cells: Cytokines and Factors
2011
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia
2005
Monoclonal antibodies in myeloma.
2015
HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients
2013
The P2X7 Receptor Sustains the Growth of Human Neuroblastoma Cells through a Substance P–Dependent Mechanism
2006
Exosomes
2019 Standout
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
2020
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
2011
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Tumor immune escape mechanisms: impact of the neuroendocrine system
2006
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Induction of a VLA-2 (CD49b)-Expressing Effector T Cell Population by a Cell-Based Neuroblastoma Vaccine Expressing CD137L
2008
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
2018
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation
2015
Innate Immune Recognition of Cancer
2015
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Wound Healing: A Cellular Perspective
2018 Standout
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
2017
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Emerging Role of Extracellular Vesicles in Bone Remodeling
2018
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience

Works of Fabio Morandi being referenced

Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
2010
CD56brightCD16− NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation
2015
Mechanisms of the Antitumor Activity of Human Vγ9Vδ2 T Cells in Combination With Zoledronic Acid in a Preclinical Model of Neuroblastoma
2013
Mechanisms of immune evasion of human neuroblastoma
2005
Interactions between HLA-G and HLA-E in Physiological and Pathological Conditions
2014
Soluble HLA-G: Are they clinically relevant?
2007
Immunogenicity of Human Neuroblastoma
2004
Immunosuppressive Microenvironment in Neuroblastoma
2013
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance
2015
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation
2013
Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+memory T cells homing to the joints in juvenile idiopathic arthritis
2005
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications
2005
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients
2011
Levels of soluble CD27 in sera and synovial fluid and its expression on memory T cells in patients with juvenile idiopathic arthritides.
2003
Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche
2014
Human Neuroblastoma Cells Trigger an Immunosuppressive Program in Monocytes by Stimulating Soluble HLA-G Release
2007
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model
2017
Binding of HLA-G to ITIM-Bearing Ig-like Transcript 2 Receptor Suppresses B Cell Responses
2014
Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated Antigens
2008
Rankless by CCL
2026